339 related articles for article (PubMed ID: 35771575)
1. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract][Full Text] [Related]
2. Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the US.
Moyers JT; Patel A; Shih W; Nagaraj G
JAMA Netw Open; 2020 Sep; 3(9):e2015656. PubMed ID: 32876684
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US.
Kerekes DM; Frey AE; Prsic EH; Tran TT; Clune JE; Sznol M; Kluger HM; Forman HP; Becher RD; Olino KL; Khan SA
JAMA Oncol; 2024 Mar; 10(3):342-351. PubMed ID: 38175659
[TBL] [Abstract][Full Text] [Related]
4. Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti-PD-1 Era.
Lamba N; Ott PA; Iorgulescu JB
JAMA Netw Open; 2022 Aug; 5(8):e2225459. PubMed ID: 36006646
[TBL] [Abstract][Full Text] [Related]
5. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database.
Gupta A; Omeogu C; Islam JY; Joshi A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
Sci Rep; 2023 May; 13(1):8190. PubMed ID: 37210410
[TBL] [Abstract][Full Text] [Related]
7. Speed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical Trials.
O'Connor JM; Fessele KL; Steiner J; Seidl-Rathkopf K; Carson KR; Nussbaum NC; Yin ES; Adelson KB; Presley CJ; Chiang AC; Ross JS; Abernethy AP; Gross CP
JAMA Oncol; 2018 Aug; 4(8):e180798. PubMed ID: 29800974
[TBL] [Abstract][Full Text] [Related]
8. Association of Race and Family Socioeconomic Status With Pediatric Postoperative Mortality.
Willer BL; Mpody C; Tobias JD; Nafiu OO
JAMA Netw Open; 2022 Mar; 5(3):e222989. PubMed ID: 35302629
[TBL] [Abstract][Full Text] [Related]
9. Patterns of care for older patients with stage IV non-small cell lung cancer in the immunotherapy era.
Kehl KL; Hassett MJ; Schrag D
Cancer Med; 2020 Mar; 9(6):2019-2029. PubMed ID: 31989786
[TBL] [Abstract][Full Text] [Related]
10. Racial Differences in Survival Among Advanced-stage Non-small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB).
Gupta A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
J Immunother; 2022 Feb-Mar 01; 45(2):132-137. PubMed ID: 34747372
[TBL] [Abstract][Full Text] [Related]
11. Patterns of immunotherapy utilization for non-small cell lung cancer in Texas pre- and post-regulatory approval.
Olateju OA; Zeng Z; Zakeri M; Sansgiry SS
Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38554190
[TBL] [Abstract][Full Text] [Related]
12. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors.
Olateju OA; Zeng Z; Thornton JD; Mgbere O; Essien EJ
BMC Cancer; 2023 Jul; 23(1):655. PubMed ID: 37442992
[TBL] [Abstract][Full Text] [Related]
13. Adoption of Innovative Therapies Across Oncology Practices-Evidence From Immunotherapy.
Carroll CE; Landrum MB; Wright AA; Keating NL
JAMA Oncol; 2023 Mar; 9(3):324-333. PubMed ID: 36602811
[TBL] [Abstract][Full Text] [Related]
14. Demographic Factors Associated With Non-Guideline-Based Treatment of Kidney Cancer in the United States.
Howard JM; Nandy K; Woldu SL; Margulis V
JAMA Netw Open; 2021 Jun; 4(6):e2112813. PubMed ID: 34106265
[TBL] [Abstract][Full Text] [Related]
15. Association of area-level socioeconomic status and non-small cell lung cancer stage by race/ethnicity and health care-level factors: Analysis of the National Cancer Database.
Gupta A; Omeogu CH; Islam JY; Joshi AR; Akinyemiju TF
Cancer; 2022 Aug; 128(16):3099-3108. PubMed ID: 35719098
[TBL] [Abstract][Full Text] [Related]
16. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
[TBL] [Abstract][Full Text] [Related]
17. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer.
Bagley AF; Anscher MS; Choi S; Frank SJ; Hoffman KE; Kuban DA; McGuire SE; Nguyen QN; Chapin B; Aparicio A; Pezzi TA; Smith GL; Smith BD; Hess K; Tang C
JAMA Netw Open; 2020 Mar; 3(3):e201255. PubMed ID: 32191331
[TBL] [Abstract][Full Text] [Related]
18. Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non-Small Cell Lung Cancer.
Kehl KL; Greenwald S; Chamoun NG; Manberg PJ; Schrag D
JAMA Netw Open; 2021 May; 4(5):e2111113. PubMed ID: 34019086
[TBL] [Abstract][Full Text] [Related]
19. Association Between Race/Ethnicity and Disparities in Health Care Use Before First-Episode Psychosis Among Privately Insured Young Patients.
Heun-Johnson H; Menchine M; Axeen S; Lung K; Claudius I; Wright T; Seabury SA
JAMA Psychiatry; 2021 Mar; 78(3):311-319. PubMed ID: 33355626
[TBL] [Abstract][Full Text] [Related]
20. Association Between Age and Survival Trends in Advanced Non-Small Cell Lung Cancer After Adoption of Immunotherapy.
Voruganti T; Soulos PR; Mamtani R; Presley CJ; Gross CP
JAMA Oncol; 2023 Mar; 9(3):334-341. PubMed ID: 36701150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]